Literature DB >> 26263076

Anatomy and Pathophysiology of Spinal Cord Injury Associated With Regional Anesthesia and Pain Medicine: 2015 Update.

Joseph M Neal1, Sandra L Kopp, Jeffrey J Pasternak, William L Lanier, James P Rathmell.   

Abstract

BACKGROUND AND OBJECTIVES: In March 2012, the American Society of Regional Anesthesia and Pain Medicine convened its second Practice Advisory on Neurological Complications in Regional Anesthesia and Pain Medicine. This update is based on the proceedings of that conference and relevant information published since its conclusion. This article updates previously described information on the pathophysiology of spinal cord injury and adds new material on spinal stenosis, blood pressure control during neuraxial blockade, neuraxial injury subsequent to transforaminal procedures, cauda equina syndrome/local anesthetic neurotoxicity/arachnoiditis, and performing regional anesthetic or pain medicine procedures in patients concomitantly receiving general anesthesia or deep sedation.
METHODS: Recommendations are based on extensive review of research on humans or employing animal models, case reports, pathophysiology research, and expert opinion.
RESULTS: The pathophysiology of spinal cord injury associated with regional anesthetic techniques is reviewed in depth, including that related to mechanical trauma from direct needle/catheter injury or mass lesions, spinal cord ischemia or vascular injury from direct needle/catheter trauma, and neurotoxicity from local anesthetics, adjuvants, or antiseptics. Specific recommendations are offered that may reduce the likelihood of spinal cord injury associated with regional anesthetic or interventional pain medicine techniques.
CONCLUSIONS: The practice advisory's recommendations may, in select cases, reduce the likelihood of injury. However, many of the described injuries are neither predictable nor preventable based on our current state of knowledge. WHAT'S NEW: Since publication of initial recommendations in 2008, new information has enhanced our understanding of 5 specific entities: spinal stenosis, blood pressure control during neuraxial anesthesia, neuraxial injury subsequent to transforaminal techniques, cauda equina syndrome/local anesthetic neurotoxicity/arachnoiditis, and performing regional anesthetic or pain procedures in patients concomitantly receiving general anesthesia or deep sedation.

Entities:  

Mesh:

Year:  2015        PMID: 26263076     DOI: 10.1097/AAP.0000000000000297

Source DB:  PubMed          Journal:  Reg Anesth Pain Med        ISSN: 1098-7339            Impact factor:   6.288


  5 in total

1.  CORR Insights®: Hypotensive Epidural Anesthesia Reduces Blood Loss in Pelvic and Sacral Bone Tumor Resections.

Authors:  Jacques T YaDeau
Journal:  Clin Orthop Relat Res       Date:  2016-05-25       Impact factor: 4.176

2.  [Intramedullary injection with tethered cord : Case report of a rare complication during spinal anesthesia].

Authors:  L Vogt; B Rodermond; P Post; S Iborra; E Stickeler; J Schiefer; J P Alt; R Rossaint; A Röhl
Journal:  Anaesthesist       Date:  2017-12-21       Impact factor: 1.041

Review 3.  The leptomeninges as a critical organ for normal CNS development and function: First patient and public involved systematic review of arachnoiditis (chronic meningitis).

Authors:  Carol S Palackdkharry; Stephanie Wottrich; Erin Dienes; Mohamad Bydon; Michael P Steinmetz; Vincent C Traynelis
Journal:  PLoS One       Date:  2022-09-30       Impact factor: 3.752

4.  Monosialoganglioside protects against bupivacaine-induced neurotoxicity caused by endoplasmic reticulum stress in rats.

Authors:  Benquan Liu; Jiemei Ji; Qing Feng; Xi Luo; Xiurong Yan; Yuxia Ni; Yajun He; Zhongxuan Mao; Jingchen Liu
Journal:  Drug Des Devel Ther       Date:  2019-02-19       Impact factor: 4.162

5.  Anterior chamber associated immune deviation used as a neuroprotective strategy in rats with spinal cord injury.

Authors:  Beatriz Pineda-Rodriguez; Diana Toscano-Tejeida; Elisa García-Vences; Roxana Rodriguez-Barrera; Adrian Flores-Romero; Daniela Castellanos-Canales; Gabriel Gutierrez-Ospina; Laura Castillo-Carvajal; Esperanza Meléndez-Herrera; Antonio Ibarra
Journal:  PLoS One       Date:  2017-11-30       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.